logo
logo

Imagene Ai Secures $21.5 Million To Push The Boundaries Of Precision Medicine For Cancer

May 02, 2022•about 3 years ago

Amount Raised

$21.5 Million

Tel Aviv

Description

Imagene AI, an emerging leader in the field of AI-based precision medicine for cancer, today announced it raised $21.5 million, comprising $3 million in seed funding led by Blumberg Capital and an $18.5 million Series A round led by renowned technology-driven cancer medicine investors Larry Ellison, Dr. David Agus, and AI imaging space pioneer Eyal Gura.

Company Information

Company

Imagene

Location

Tel Aviv, Tel Aviv District, Israel

About

” “Imagene is honored to have the support of visionary investors – leaders at the forefront of technology-driven cancer research – who embrace our mission of revolutionizing cancer diagnosis and transforming patient care,” said Dean Bitan, Imagene co-founder and chief executive officer.

FundzWatch™ Score

69
Medium Activity

Buyer Intent Analysis

Get personalized insights on buying likelihood

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech